Výsledky vyhledávání - "Galiavich AS"

Akademický článek

First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension

Autor: I. E. Chazova, T. V. Martynyuk, V. O. Rodnenkov, B. Sh. Gorieva, A. N. Rogoza, M. V. Arkhipov, Yu. I. Grinshtein, O. D. Ostroumova, A. S. Galiavich, O. P. Rotar’, L. A. Haisheva, T. R. Kameneva

Publikováno v: Системные гипертензии, Vol 17, Iss 2, Pp 36-47 (2020)

Abstract VICTORY II study objective. Evaluation of Vamloset and Co-Vamloset safety and effectiveness in reaching target blood pressure (BP) level in patients with stages 23 arterial hypertension (AH). Materials and methods. Russian multicenter

Externí odkaz: https://doaj.org/article/d10d2629c2744a8cb865611fbf570069

Zobrazit plný text záznamu

Akademický článek

A fixed-dose lisinopril and amlodipine combination in conjunction with rosuvastatin in patients with hypertensive disease and coronary heart disease

Autor: Z M Galeeva, A S Galiavich

Publikováno v: Терапевтический архив, Vol 86, Iss 9, Pp 71-76 (2014)

AIM. To evaluate the efficacy and safety of a fixed-dose combination of the angiotensin-converting enzyme inhibitor lisinopril 10 mg and the calcium antagonist amlodipine 5 mg (ekvator) in conjunction with rosuvastatin (mertenil). MATERIALS AND METHO

Externí odkaz: https://doaj.org/article/b925f36a6a604e82b28ea4eb257ac73f

Zobrazit plný text záznamu

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II

Autor: A N Rogoza, Oxana Rotar, Tamila Martynyuk, Shurat B. Gorieva, Tatiana R. Kameneva, Yury I. Grinshtein, Albert S. Galiavich, Mikhail V. Arkhipov, Olga D. Ostroumova, O. V. Rodnenkov, I E Chazova, L. A. Khaisheva

Publikováno v: Системные гипертензии, Vol 17, Iss 3, Pp 59-70 (2020)

Aim. Assessment of Vamloset® and Co-Vamloset effects on blood pressure target levels and indicators associated with organ protection: albuminuria; elasticity of arteries and central aortic pressure (CAP); endothelial function; tumor necrosis factor-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29e0b648560e699afeadff1e80f39e93
https://doi.org/10.26442/2075082x.2020.3.200414

Zobrazit plný text záznamu

First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension

Autor: L A Haisheva, A. N. Rogoza, Yu. I. Grinshtein, Olga D. Ostroumova, O. P. Rotar, A. S. Galiavich, B. Sh. Gorieva, I E Chazova, M. V. Arkhipov, T. R. Kameneva, V. O. Rodnenkov, Tamila Martynyuk

Publikováno v: Системные гипертензии, Vol 17, Iss 2, Pp 36-47 (2020)

VICTORY II study objective. Evaluation of Vamloset and Co-Vamloset safety and effectiveness in reaching target blood pressure (BP) level in patients with stages 23 arterial hypertension (AH). Materials and methods. Russian multicenter prospective cli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63bda42a6d834674883f8ecc0ca55334
https://doi.org/10.26442/2075082x.2020.2.200123

Zobrazit plný text záznamu

Akademický článek

The history of the Kazan School of Therapists (on the occasion of the 200th anniversary of the Kazan State Medical University)

Autor: A S Sozinov, D I Abdulganieva, A S Galiavich, R F Khamitov, L A Khusnutdinova, T N Khalfina, N G Shamsutdinova, É R Kirillova

Publikováno v: Терапевтический архив, Vol 86, Iss 5, Pp 120-122 (2014)

The history of the Kazan School of Therapists numbers two centuries of scientific achievements and discoveries. German Professors F.H. Erdman and K.F. Fuks laid the groundwork for clinical teaching continued by Russian therapists N.A. Skandovsky, N.A

Externí odkaz: https://doaj.org/article/738f70c6bbb74339bd759cfd67362057

Zobrazit plný text záznamu

Akademický článek

Mildronate efficacy and tolerance in chronic heart failure patients therapy

Autor: A. S. Galiavich, Z. M. Galeeva, Z. V. Baleeva

Publikováno v: Российский кардиологический журнал, Vol 0, Iss 5, Pp 55-59 (2005)

Externí odkaz: https://doaj.org/article/f1ebbd3b8d264179bcbddc4553088cb8

Zobrazit plný text záznamu

[Effect of antihypertensive drugs on some humoral parameters of endothelial function]

Autor: A S, Galiavich, A R, Khamidullina, R A, Galiavich

Publikováno v: Kardiologiia. 49(5)

We assessed effect of antihypertensive drugs from various classes on humoral parameters of endothelial function - levels of asymmetrical dimethyl-arginine (ADMA) and metabolites of nitrous oxide (MNO) - in 106 patients with I-II degree arterial hyper

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4f660a9d1e0f5686434d4f184dbc5557
https://pubmed.ncbi.nlm.nih.gov/19463132

Zobrazit plný text záznamu

[Regional results of the program FORTISSIMO in Kazan]

Autor: A S, Galiavich, R A, Galiavi, L V, Baleeva

Publikováno v: Kardiologiia. 53(7)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b6af1ee5d6ffc4a3de4b1a28fe008817
https://pubmed.ncbi.nlm.nih.gov/24087957

Zobrazit plný text záznamu

[CYP2C19 gene polymorphism in patients with myocardial infarction who use clopidogrel]

Autor: A S, Galiavich, D D, Valeeva, R Sh, Minnetdinov, A A, Arkhipova, I I, Akhmetov, R A, Galiavi

Publikováno v: Kardiologiia. 52(4)

One of the foundations of the modern treatment of myocardial infarction (MI) is a combination antiplatelet therapy consisting of acetylsalicylic acid (ASA) and clopidogrel. Pharmacodynamic and clinical studies have demonstrated that the polymorphism

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::062b1ba201f8f7d7c358ac571efaa4fe
https://pubmed.ncbi.nlm.nih.gov/22839512

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání